|  | | | | |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Ranibizumab (Lucentis®) (mAb-based) ELISA | Acid Labile Subunit (ALS) ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Proinsulin (Intact) LUM Assay | Varicella-Zoster Virus (VZV) IgG ELISA |
| Catalog Number | TM09034 | E35 | 27600 | IV2-002 | IB79889 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay for the specific determination of free Ranibizumab in aqueous humour. For research use only - not for use in diagnostic procedures. Not for use in serum or plasma. | Enzyme immunoassay (ELISA) for the determination of Acid Labile Subunit (ALS) in serum and plasma (heparin, EDTA, citrate). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro diagnostics.... Read More | The Varicella-Zoster Virus (VZV) IgG ELISA is intended for the determination of IgG class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. |
| Detection Target | Normetanephrine | Immunoglobulin A (IgA) | Metanephrine / Normetanephrine | IGFBP-3 | Strongyloides IgG / IgM |
| Sample Type | Urine | Serum, plasma, tissue homogenates and other biological fluids. | Urine | Serum, Blood Plasma, Follicular Fluid, Seminal Blood Plasma | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Luminescence (LUM) Assay | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 10 - 300 ng/mL | 1.5 to 40.0 mU/mL ALS | 1.56 to 100.0 ng/mL | 1.5 to 110.0 pmol/L | A cut-off control is used for the interpretation of results. |
| Sensitivity | 23 ng/mL | 0.469 ng/ml | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 0.5 ng/mL | 0.879 |
| Assay Time | 2 hour, 15 min. total incubation time. | 3 hrs (incubation) | 2 hours (incubation) | 3 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |